Diamond Hill Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,010,175
| Closed | -$180M | – | 175 |
|
2024
Q4 | $180M | Sell |
1,010,175
-307,509
| -23% | -$54.6M | 0.79% | 49 |
|
2024
Q3 | $260M | Sell |
1,317,684
-39,080
| -3% | -$7.72M | 1.05% | 42 |
|
2024
Q2 | $233M | Buy |
1,356,764
+13,787
| +1% | +$2.36M | 1% | 47 |
|
2024
Q1 | $245M | Sell |
1,342,977
-1,891
| -0.1% | -$344K | 1% | 48 |
|
2023
Q4 | $208M | Buy |
1,344,868
+29,550
| +2% | +$4.58M | 0.92% | 49 |
|
2023
Q3 | $196M | Sell |
1,315,318
-14,249
| -1% | -$2.12M | 0.95% | 46 |
|
2023
Q2 | $179M | Buy |
1,329,567
+3,874
| +0.3% | +$522K | 0.81% | 51 |
|
2023
Q1 | $211M | Sell |
1,325,693
-24,979
| -2% | -$3.98M | 0.99% | 44 |
|
2022
Q4 | $218M | Sell |
1,350,672
-197,335
| -13% | -$31.9M | 0.99% | 46 |
|
2022
Q3 | $208M | Sell |
1,548,007
-66,975
| -4% | -$8.99M | 1% | 43 |
|
2022
Q2 | $247M | Sell |
1,614,982
-265,808
| -14% | -$40.7M | 1.08% | 39 |
|
2022
Q1 | $305M | Sell |
1,880,790
-331,112
| -15% | -$53.7M | 1.13% | 37 |
|
2021
Q4 | $299M | Sell |
2,211,902
-147,089
| -6% | -$19.9M | 1.07% | 37 |
|
2021
Q3 | $254M | Buy |
2,358,991
+46,301
| +2% | +$4.99M | 0.97% | 42 |
|
2021
Q2 | $261M | Buy |
2,312,690
+44,704
| +2% | +$5.04M | 0.99% | 42 |
|
2021
Q1 | $245M | Buy |
2,267,986
+2,152,780
| +1,869% | +$233M | 0.99% | 41 |
|
2020
Q4 | $12.3M | Buy |
115,206
+4,114
| +4% | +$441K | 0.06% | 121 |
|
2020
Q3 | $9.73M | Hold |
111,092
| – | – | 0.05% | 117 |
|
2020
Q2 | $10.9M | Buy |
+111,092
| New | +$10.9M | 0.06% | 115 |
|